![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Szymaszkiewicz, A.; Malkiewicz, A.; Storr, M.; Fichna, J. und Zielinska, M.
(2019):
THE PLACE OF TACHYKININ NK2 RECEPTOR ANTAGONISTS IN THE TREATMENT DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME.
In: Journal of Physiology and Pharmacology, Bd. 70, Nr. 1: S. 15-23
Mosinska, P.; Jacenik, D.; Salaga, M.; Wasilewski, A.; Cygankiewicz, A.; Sibaev, A.; Mokrowiecka, A.; Malecka-Panas, E.; Pintelon, I.; Storr, M.; Timmermans, J. P.; Krajewska, W. M. und Fichna, J.
(2018):
FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS.
In: Neurogastroenterology and Motility, Bd. 30, Nr. 5, e13272
Bashashati, M.; Fichna, J.; Piscitelli, F.; Capasso, R.; Izzo, A. A.; Sibaev, A.; Timmermans, J.-P.; Cenac, N.; Vergnolle, N.; Marzo, V. di und Storr, M.
(2017):
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT).
In: Neurogastroenterology and Motility, Bd. 29, Nr. 12, e13148
Zielinska, M.; Fichna, J.; Bashashati, M.; Habibi, S.; Sibaev, A.; Timmermans, J.-P. und Storr, M.
(2017):
G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain.
In: Neurogastroenterology and Motility, Bd. 29, Nr. 7, e13025
Salaga, M.; Zatorski, H.; Zielinska, M.; Mosinska, P.; Timmermans, J.-P.; Kordek, R.; Storr, M. und Fichna, J.
(2017):
Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice.
In: Naunyn-Schmiedebergs Archives of Pharmacology, Bd. 390, Nr. 10: S. 1015-1027
Hasenoehrl, C.; Taschler, U.; Storr, M. und Schicho, R.
(2016):
The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.
In: Neurogastroenterology and Motility, Bd. 28, Nr. 12: S. 1765-1780